Pharmacologic management of arrhythmias in patients with congenital heart disease

American Journal of Cardiovascular Drugs

Volumn 1, Issue 2, 2001, Pages 91-103

  Batra, Anjan S ^a   Luna, Carlos F ^a   Silka, Michael J ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; DRUG INTERACTION; HEART ARRHYTHMIA; HUMAN; PATHOPHYSIOLOGY; REVIEW;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CLINICAL TRIALS; DRUG INTERACTIONS; HEART DEFECTS, CONGENITAL; HUMANS;

EID: 1842459622     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/00129784-200101020-00003     Document Type: Review

References (86)

1. Vaughan Williams EM. Classification of antiarrhythmic drugs. In: Sandoc E, Flensted-Jensen E, Olsen KH, editors. Cardiac arrhythmias. Sodrtalje, Sweden: Astra, 1970: 449-72
2. Epstein ML. Congenital stenosis and insufficiency of the tricuspid valve. In: Emmanoulides GC, Memensschneider TA, Allen HD, et al., editors. Heart disease in infants, children and adolescents 5th ed. Baltimore (MD): William & Wilkins, 1995: 919-29
3. Freedom RM, Dyck JD. Congenitally corrected transposition of great arteries. In: Emmanoulides GC, Memensschneider TA, Allen HD, et al., editors. Heart disease in infants children and adolescents 5th ed. Baltimore (MD): William & Wilkins, 1995: 1225-45
4. Silka MJ, McAnulty JH. Arrhythmias in patients with congenital heart disease. Card Electrophysiol Rev 1997; 1-2: 237-40
5. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: pediatric advanced life support. Circulation 2000; 102: I-312
6. Bink-Boelkens MT, Velvis H, Van der Heide JJ, et al. Dysrhythmias after atrial surgery in children. Am Heart J 1983; 106: 125-30
7. Gewillig M, Wyse RK, de Leval MR, et al. Early and late arrhythmias after the fontan operation: predisposing factors and clinical consequences. Br Heart J 1992; 67: 72-9
8. Duster MC, Bink-Boelkens MT, Wampler D, et al. Long term follow-up of dysrhythmias following the Mustard procedure. Am Heart J 1985; 109: 1323-6
9. Wittig JH, DeLeval MR, Stark J, et al. Intraoperative mapping of atrial activation before, during and after the Mustard operation. J Thorac Cardiovasc Surg 1977; 73: 1-13
10. Vetter VL, Tanner CS, Horowitz LN. Electrophysiologic consequences of the Mustard repair of d-transposition of the great arteries. J Am Coll Cardiol 1987; 10: 1265-73
11. Deanfield J, Camm J, Macartney F, et al. Arrhythmia and late mortality after Mustard and Senning operation for transposition of the great arteries: an eight year prospective study. J Thorac Cardiovasc Surg 1988; 96: 569-76
12. Kavey RE, Gaum WE, Byrum CJ, et al. Loss of sinus rhythm after cavopulmonary connection. Circulation 1995; 92: II304-8
13. Heinz G, Kractowzel C, Schmid, et al. Sinus node dysfunction after orthotopic heart transplantation: the Vienna experience. Pacing Clin Electrophysiol 1994; 17: 2057-63
14. Winslow AJ, Papagiannis J, Kanter RJ. Acute treatment of arrhythmia. In: Guillette PC, Garson A, editors. Clinical pediatric arrhythmias. 2nd ed. Phiadelphia (PA): WB Saunders Company, 1999: 149-63
15. Huhta JC, Maloney JD, Ritter DG, et al. Complete atrioventricular block in patients with atrioventricular discordance. Circulation 1983; 67: 1374-7
16. Lev M, Silverman J, Fitzmaurice FM, et al. Lack of connection between the atria and the more peripheral conduction system in congenital atrioventricular block. Am J Cardiol 1971; 27: 481-98
17. Weindling SN, Saul JP, Gamble WJ, et al. Duration of complete atrio ventricular block. Am J Cardiol 1998; 82: 528-31
18. Perry JC, Walsh EP. Diagnosis and management of cardiac arrhythmia. In: Chang AC, Hanley FL, Wernovsky G, et al., editors. Pediatric cardiac intensive care. Baltimore (MD): Williams & Wilkins, 1998: 461-81
19. American Heart Association, Emergency Cardiac Care Committee and Subcommittees. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. JAMA 1992; 268: 2171-295
20. Fish F, Benson Jr W. Disorders of cardiac rhythm and conduction. In: Emmanoulides GC, Memensschneider TA, Allen HD, et al., editors. Heart disease in infants, children and adolescents. 5th ed. Baltimore (MD): William & Wilkins, 1995: 1555-603
21. Gregorates G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998; 31: 1175-209
22. Jacobsen JR, Bryant RM, Garson A. Irregular heart beat. In: Garson A, Bricker JT, Fisher DJ, et al., editors. The science and practice of pediatric cardiology. 2nd ed. Baltimore (MD): Williams & Wilkins, 1998: 2219-26
23. Porter CJ, Holmes DR. Preexcitation syndrome associated with congenital heart disease. In: Benditt DG, Benson Jr DW, editors. Cardiac preexcitation syndromes. Boston (MA): Martinus Nijhoff, 1986: 289-302
24. Kanter RJ, Papagiannis J, Carboni MP, et al. Radiofrequency catheter ablation of supraventricular tachycardia substrates after Mustard and Senning operations for d-transposition of the great arteries. J Am Coll Cardiol 2000; 35: 428-41
25. Perry JC. Supraventricular tachycardia. In: Garson A, Bricker JT, Fisher DJ, et al., editors. The science and practice of pediatric cardiology. 2nd ed. Baltimore (MD): Williams & Wilkins, 1998: 2059-102
26. Perry JC. Medical antiarrhythmic therapy. In: Guillette PC, Garson A, editors. Clinical pediatric arrhythmias. 2nd ed. Philadelphia (PA): WB Saunders Company, 1999: 231-48
27. Wilbur SL, Marchlinski FE. Adenosine as an anthyarrhythmic agent. Am J Cardiol 1997; 79 (12A): 30-37
28. Crosson JE, Etheridge SP, Melstein S, et al. Therapeutic and diagnostic utility of adenosine during tachycardia evaluation in children. Am J Cardiol 1994; 74: 155-60
29. Losek JD, Endom E, Dietrich A, et al. Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review. Ann Emerg Med 1999; 33: 185-91
30. Mulla N, Karpawich PP. Ventricular fibrillation following adenosine therapy for supraventricular tachycardia in a neonate with concealed Wolf Parkinson- White syndrome treated with digoxin. Pediatr Emerg Care 1995; 11: 238-9
31. DeGroff CG, Silka MJ. Bronchospasm after intravenous administration of adenosine in patient with asthma. J Pediatr 1994; 125: 822-3
32. Sellers TD, Bashore TM, Gallagher JJ. Digitalis in the preexcitation syndromes: analysis during atrial fibrillation. Circulation 1977; 56: 260-7
33. Soult JA, Munoz M, Lopez JD, et al. Efficacy and safety of intravenous amiodarone for short term treatment of paroxysmal supraventricular tachycardia in children. Pediatr Cardiol 1995; 16: 16-9
34. Figa FH, Gow RM, Hamilton RM, et al. Clinical efficacy and safety of intravenous amiodarone in infants and children. Am J Cardiol 1994; 74: 573-7
35. Perry JC, Fenrich AL, Hulse JE, et al. Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol 1996; 27: 1246-50
36. Paul T, Guccione P. New antiarrhythmic drugs in pediatric use: amiodarone. Pediatr Cardiol 1994; 15: 132-8
37. Daniels CJ, Schutte DA, Hammond S, et al. Acute pulmonary toxicity in an infant from intravenous amiodarone. Am J Cardiol 1997; 80: 1113-6
38. Smith TW. Digitalis toxicity: epidimeology and clinical use of serum concentration measurements. Am J Med 1975; 58: 470-6
39. Woosley RL, Drayer DE, Reidenberg MM, et al. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med 1978; 298: 1157-9
40. O?Sullivan JJ, Gardiner HM, Wren C. Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants? J Am Coll Cardiol 1995; 26: 991-4
41. Fenrich Jr AL, Perry JC, Friedman RA. Flecainide and amiodorone: combined therapy for refractory tachyarrhythmias in infancy. J Am Coll Cardiol 1995; 25: 1195-8
42. Drago F, Mazza A, Guccione P, et al. Amiodorone used alone or in combination with propranolol: a effective therapy for tachyarrhythmias in infants and children. Pediatr Cardiol 1998; 19: 445-9
43. Etheridge SP, Judd VE. Supraventricular tachycardia in infancy: evaluation, management and follow-up. Arch Pediatr Adolesc Med 1999; 153: 267-71
44. Fish FA, Gillette PC, Benson Jr DW. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric electrophysiology group. J Am Coll Cardiol 1991; 18: 356-65
45. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-12
46. Janousek J, Paul T. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study Working Group on Pediatric Arrhythmias and Electrophysiology the Association of European Pediatric Cardiologists. Am J Cardiol 1998; 81: 1121-4
47. Pfammatter JP, Paul T, Lehmann C, et al. Efficacy and proarrhythmia of oral sotalol in pediatric patient. J Am Coll Cardiol 1995; 26: 1002-7
48. Maragnes P, Tipple M, Fournier A. Effectiveness of oral sotalol for treatment of pediatric arrhythmias. Am J Cardiol 1992; 69: 751-4
49. Thorne SA, Barnes I, Cullinan P, et al. Amiodorone-associated thyroid dysfunction: risk factors in adolescents with congenital heart disease. Circulation 1999; 100: 149-54
50. Anon. Cordarone? (amiodarone hydrochloride). Physicians?s desk reference. Montvale (NJ): Medical Economics Company, 1999: 3283-9
51. Perry JC, Mcquinn RL, Smith Jr RT, et al. Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics. J Am Coll Cardiol 1989; 14: 185-91
52. Van Hare GF, Lesh MD, Stanger P. Radiofrequency catheter ablation of supraventricular arrhythmias in patients with congenital heart disease: results and technical considerations. J Am Coll Cardiol 1993; 22: 883-90
53. Dubin AM, Van Hare GF. Radiofrequency catheter ablation: indications and complications. Pediatr Cardiol 2000; 21: 551-6
54. Garson Jr A, Bink-Boelkens M, Hesslein PS, et al. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol 1985; 6: 871-8
55. Murray KT. Ibutilide. Circulation 1998; 97: 493-7
56. VanderLugt JT, Mattioni T, Denker S, et al. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmia after cardiac surgery. Circulation 1999; 100: 369-75
57. Ellenbogen KA, Stambler BS, Wood MA, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation or atrial flutter: a dose response study. J Am Coll Cardiol 1996; 28: 130-6
58. Stambler BS, Wood MA, Ellembogen KA, et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996; 94: 1613-21
59. Volgman AS, Stambler BS, Kappagoda C, et al. Comparison of intravenous ibutilide versus procainamide for rapid termination of atrial fibrillation or flutter [abstract]. Pacing Clin Electrophysiol 1996; 19: 608
60. Oral H, Souza JJ, Michaud JF, et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 1999; 340: 1849-54
61. Van Hare GF, Porter CB. Atrial flutter and atrial fibrillation. In: Garson A, Bricker JT, Fisher DJ, et al., editors. The science and practice of pediatric cardiology. 2nd ed. Baltimore (MD): Williams & Wilkins, 1998: 2103-20
62. Balaji S, Johnson TB, Sade RM, et al. Management of atrial flutter after the Fontan procedure. J Am Coll Cardiol 1994; 23: 1209-15
63. Weindling SN, Saul JP, Triedman JK, et al. Current intra-atrial reentry tachycardia following congenital heart disease surgery: the search for an optimum therapy [abstract]. Circulation 1995; 92: I-765
64. Beaufort-Krol GC, Bink-Boelkens MT. Sotalol for atrial tachycardias after surgery for congenital heart disease. Pacing Clin Electrophysiol 1997; 20: 2125-9
65. Pfammatter JP, Paul T. New antiarrhythmic drug in pediatric use: sotalol. Pediatr Cardiol 1997; 18: 28-34
66. Naheed ZJ, Strasburger JF, Benson Jr W, et al. Natural history and management strategies of automatic atrial tachycardia in children. Am J Cardiol 1995; 75: 405-7
67. Bauersfeld U, Gow RM, Hamilton RM, et al. Treatment of atrial ectopic tachycardia in infants < 6 months. Am Heart J 1995; 129: 1145-8
68. Salim MA, Case CL, Gillette PC. Chaotic atrial tachycardia in children. Am Heart J 1995; 129: 831-3
69. Yeager SB, Hougen TJ, Levy AM. Sudden death in infants with chaotic atrial rhythm. Am J Dis Child 1984; 138: 689-92
70. Dodo H, Gow RM, Hamilton RM, et al. Chaotic atrial rhythm in children. Am Heart J 1995; 129: 990-5
71. Walsh EP, Saul P, Sholler GF, et al. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol 1997; 29: 1046-53
72. Villain E, Vetter VL, Garcia JM, et al. Evolving concepts in the management of congenital junctional ectopic tachycardia: a multicenter study. Circulation 1990; 81: 1544-9
73. Silka MJ. Emergency management of arrhythmias. In: Deal B, Wolff G, Gelband H, editors. Current concepts in diagnosis and management of arrhythmias in infants and children. Armonk (NY): Futura Publishing Co., Inc., 1998: 309-28
74. Coumel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children, one hundred and thirty-five cases. Am Heart J 1980; 100: 1063-9
75. Garson A, Gillette PC, McVey P, et al. Amiodarone treatment of critical arrhythmias in children and young adults. J Am Coll Cardiol 1984; 4: 749-55
76. Raja P, Hawker RE, Chaikitpinyo A, et al. Amiodarone management of junctional ectopic tachycardia after cardiac surgery in children. Br Heart J 1994; 72: 261-5
77. Celiker A, Ceviz N, Ozme S. Effectiveness and safety of intravenous amiodarone in drug-resistant tachyarrhythmias of children. Acta Paediatr Jpn 1998; 40: 567-72
78. Cilliers AM, du Plessis JP, Clur SA, et al. Junctional ectopic tachycardia in six pediatric patients. Heart 1997; 78: 413-5
79. Murphy JG, Gersh BJ, Mair DD, et al. Long term outcome in patients undergoing surgical repair of tetralogy of fallot. N Engl J Med 1993; 329: 593-9
80. Garson Jr A, Nihill MR, McNamara DG, et al. Status of the adult and adolescent after repair of tetralogy of Fallot. Circulation 1979; 59: 1232-40
81. Gatzoulis MA, Till JA, Redington AN. Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot: the substrate for malignant ventricular tachycardia? Circulation 1997; 95: 401-4
82. Mildon SW, Brady WJ, Berger S, et al. Pediatric ventricular tachycardia, a review with three illustrative cases. Pediatr Emerg Care 1994; 10: 294-300
83. Connolly S. Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999; 100: 2025-34
84. Gorgels AP, Van den Dool A, Hof A, et al. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol 1996; 78: 43-6
85. Garson Jr A, Randall DC, Gillette PC, et al. Prevention of sudden death after repair of tetralogy of fallot: treatment of ventricular arrhythmias. J Am Coll Cardiol 1985; 6: 221-7
86. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999; 341: 871-8